Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists (Q55053431)

16 June 2018

title

Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists (English)

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

15 July 2024

0 references

1 reference

1 reference

1 reference

ankylosing spondylitis

1 reference

4

Cem Gabay

1 reference

16 June 2018

Laure Brulhart

1

1 reference

16 June 2018

Paola Chevallier

3

1 reference

16 June 2018

Michael J. Nissen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20851032

15 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20851032

15 July 2024

publication date

20 September 2010

1 reference

16 June 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S1297319X10002150?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

https://api.elsevier.com/content/article/PII:S1297319X10002150?httpAccept=text/plain

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

15 July 2024

1 reference

16 June 2018

volume

77

1 reference

16 June 2018

issue

6

1 reference

16 June 2018

page(s)

625-626

1 reference

16 June 2018

Treatment of ankylosing spondylitis and other spondyloarthritides

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period

15 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis.

15 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases

15 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis

15 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab

15 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

15 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

15 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JBSPIN.2010.08.004

15 July 2024

Identifiers

1 reference

16 June 2018

1 reference

16 June 2018